Support Alert

COVID-19 therapy: corticosteroids including dexamethasone and hydrocortisone

In accordance with World Health Organization (WHO) recommendations, systemic corticosteroids should be used in patients with severe and critical COVID-19 disease, but not in patients with non-severe COVID-19.

Click here to view further detail of the recommendation on systemic corticosteroids and COVID-19.

Medical staff should follow this guidance in the management of COVID-19. Hospital clinical pharmacists should ensure prescribing guidance is followed.


Email newsletter

Want the latest pharmacy news and updates straight to your inbox?

Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.

Sign Up